<DOC>
	<DOCNO>NCT00003935</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Radiation therapy use high-energy x-rays damage tumor cell . Combining one drug radiation therapy may kill tumor cell . PURPOSE : Phase I trial study effectiveness vincristine plus etoposide radiation therapy treat child newly diagnose brain stem glioma .</brief_summary>
	<brief_title>Combination Chemotherapy Plus Radiation Therapy Treating Children With Newly Diagnosed Brain Stem Glioma</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate efficacy vincristine plus etoposide concurrent radiotherapy one year survival child newly diagnose diffuse intrinsic brain stem glioma . II . Assess toxicity regimen patient population . OUTLINE : Induction : Patients receive oral etoposide daily day 1-21 vincristine IV day 1 , 8 , 15 . Treatment repeat every 4 week 2 course . Patients receive radiotherapy daily 6 week concurrently induction chemotherapy . Maintenance : One week induction therapy , patient receive vincristine IV day 1 8 oral etoposide daily day 1-21 . Treatment repeat every 4 week 10 course absence disease progression unacceptable toxicity . Patients follow every 3 month 2 year , every 6 month 3 year , annually thereafter . PROJECTED ACCRUAL : A total 30 patient accrue study within 2 year .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Newly diagnose diffuse intrinsic brain stem glioma MRI At least 2/3 tumor pons Tumor origin clearly pons At least 2 clinical feature le 6 month duration : Cranial nerve deficit Long tract sign Ataxia No diffuse brain stem enlargement secondary neurofibromatosis No diffuse leptomeningeal disease PATIENT CHARACTERISTICS : Age : 3 21 Performance status : Karnofsky Lansky 50100 % Life expectancy : Not specify Hematopoietic : Absolute neutrophil count least 1,000/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin le 2.0 mg/dL ALT great 5 time upper limit normal Renal : Creatinine GFR normal age PRIOR CONCURRENT THERAPY : Biologic therapy : No prior biologic therapy Chemotherapy : No concurrent chemotherapy No prior chemotherapy Endocrine therapy : Prior glucocorticoid allow Radiotherapy : No prior radiotherapy Surgery : No prior surgery Other : No concurrent investigational drug</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>untreated childhood brain stem glioma</keyword>
</DOC>